Search research articles
Contact Us
Filters
Showing results (491-500 of 675) with videos related to
Page
of 68
Sort By:
Southern African Journal of Infectious Diseases
|
December 9, 2022
D-dimers in omicron versus delta: A retrospective analysis
Alon H Shulman, Barry Jacobson, Bradley M Segal, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 9, 2004
TLR9 is localized in the endoplasmic reticulum prior to stimulation
Cynthia A Leifer, Margaret N Kennedy, Alessandra Mazzoni, et al.
The Journal of Clinical Investigation
|
September 19, 2018
CNS-resident classical DCs play a critical role in CNS autoimmune disease
David A Giles, Patrick C Duncker, Nicole M Wilkinson, et al.
Immunity
|
March 1, 1995
Construction of a functional disulfide-stabilized TCR Fv indicates that antibody and TCR Fv frameworks are very similar in structure
Y Reiter, I Kurucz, U Brinkmann, et al.
The Journal of Biological Chemistry
|
April 17, 1999
Endostatin induces endothelial cell apoptosis
M Dhanabal, R Ramchandran, M J Waterman, et al.
The European Journal of Neuroscience
|
April 12, 2001
Neurotrophins act at presynaptic terminals to activate synapses among cultured hippocampal neurons
C Collin, C Vicario-Abejon, M E Rubio, et al.
Experimental Hematology
|
October 1, 1993
Constitutive and induced expression of hematopoietic growth factor genes by fibroblasts from children with Fanconi anemia
G C Bagby, G M Segal, A D Auerbach, et al.
Neuroscience
|
February 1, 1995
N-methyl-D-aspartate receptors are critical for mediating the effects of glutamate on intracellular calcium concentration and immediate early gene expression in cultured hippocampal neurons
H Bading, M M Segal, N J Sucher, et al.
Neurochemistry International
|
December 2, 2008
Antioxidant effect of ethyl pyruvate in respiring neonatal cerebrocortical slices after H(2)O(2) stress
J Liu, M Segal, S Yoo, et al.
The Lancet. Neurology
|
August 16, 2008
Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study
Benjamin M Segal, Cris S Constantinescu, Aparna Raychaudhuri, et al.
Page
of 68
Search research articles
Search
Showing results (491-500 of 675) with videos related to
Sort By:
Page
of 68
Southern African Journal of Infectious Diseases
|
December 9, 2022
D-dimers in omicron versus delta: A retrospective analysis
Alon H Shulman, Barry Jacobson, Bradley M Segal, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 9, 2004
TLR9 is localized in the endoplasmic reticulum prior to stimulation
Cynthia A Leifer, Margaret N Kennedy, Alessandra Mazzoni, et al.
The Journal of Clinical Investigation
|
September 19, 2018
CNS-resident classical DCs play a critical role in CNS autoimmune disease
David A Giles, Patrick C Duncker, Nicole M Wilkinson, et al.
Immunity
|
March 1, 1995
Construction of a functional disulfide-stabilized TCR Fv indicates that antibody and TCR Fv frameworks are very similar in structure
Y Reiter, I Kurucz, U Brinkmann, et al.
The Journal of Biological Chemistry
|
April 17, 1999
Endostatin induces endothelial cell apoptosis
M Dhanabal, R Ramchandran, M J Waterman, et al.
The European Journal of Neuroscience
|
April 12, 2001
Neurotrophins act at presynaptic terminals to activate synapses among cultured hippocampal neurons
C Collin, C Vicario-Abejon, M E Rubio, et al.
Experimental Hematology
|
October 1, 1993
Constitutive and induced expression of hematopoietic growth factor genes by fibroblasts from children with Fanconi anemia
G C Bagby, G M Segal, A D Auerbach, et al.
Neuroscience
|
February 1, 1995
N-methyl-D-aspartate receptors are critical for mediating the effects of glutamate on intracellular calcium concentration and immediate early gene expression in cultured hippocampal neurons
H Bading, M M Segal, N J Sucher, et al.
Neurochemistry International
|
December 2, 2008
Antioxidant effect of ethyl pyruvate in respiring neonatal cerebrocortical slices after H(2)O(2) stress
J Liu, M Segal, S Yoo, et al.
The Lancet. Neurology
|
August 16, 2008
Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study
Benjamin M Segal, Cris S Constantinescu, Aparna Raychaudhuri, et al.
Page
of 68